Back to Search
TIMOTHY MANSOUR, M.D.
M.D.
Surgery Physician
NPI: 1851786727IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
MD225603(OR)35715(AL)
CMS Specialties
PrimaryGENERAL SURGERY
Education
UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Class of 2015
Research & Publications (20)
Naphthyl tetronic acids as multi-target inhibitors of bacterial peptidoglycan biosynthesis.
PMID 17600795·ChemMedChem·2007
8-other
On the absolute configuration in 1,4-dihydrothiazepine covalent complexes derived from inhibition of class A and C beta-lactamases with 6-methylidene penems.
PMID 17868160·ChemMedChem·2007
8-other
Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model.
PMID 19673466·J Med Chem·2009
7-preclinical
Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.
PMID 19317452·J Med Chem·2009
7-preclinical
Kinase domain mutations in cancer: implications for small molecule drug design strategies.
PMID 19239229·J Med Chem·2009
8-other
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.
PMID 19584280·Cancer Res·2009
7-preclinical
A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).
PMID 19278250·J Med Chem·2009
7-preclinical
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines.
PMID 19645448·J Med Chem·2009
7-preclinical
2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer.
PMID 19640711·Bioorg Med Chem Lett·2009
7-preclinical
Oxidative palladium catalysis in S(N)Ar reactions leading to heteroaryl ethers from pyridotriazol-1-yloxy heterocycles with aryl boronic acids.
PMID 19265423·J Am Chem Soc·2009
8-other
Pyranonaphthoquinone lactones: a new class of AKT selective kinase inhibitors alkylate a regulatory loop cysteine.
PMID 19309081·J Med Chem·2009
8-other
A new modification in the porous polyethylene-coated lester jones tube.
PMID 19229741·Orbit·2009
8-other
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.
PMID 19001109·Antimicrob Agents Chemother·2009
4-observational
Heteroaryl ethers by oxidative palladium catalysis of pyridotriazol-1-yloxy pyrimidines with arylboronic acids.
PMID 19514789·Org Lett·2009
8-other
Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.
PMID 18559648·Antimicrob Agents Chemother·2008
8-other
Piperazine sulfonamides as potent, selective, and orally available 11beta-hydroxysteroid dehydrogenase type 1 inhibitors with efficacy in the rat cortisone-induced hyperinsulinemia model.
PMID 18578516·J Med Chem·2008
7-preclinical
The discovery of pyrano[3,4-b]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activity.
PMID 18729128·ChemMedChem·2008
7-preclinical
Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24.
PMID 18798205·ChemMedChem·2008
8-other
Targeting Val 216 in class A beta-lactamases with tricyclic 6-methylidene penems.
PMID 18924212·ChemMedChem·2008
8-other
Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary study.
PMID 18959789·BMC Res Notes·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 9155 SW Barnes Rd Ste 735
Portland, OR 97225 - Phone
- (503) 935-8379
Quick Facts
- NPI
- 1851786727
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile